Skip to main content
TipRanks
Go Ultimate75% OFF

FALCO HOLDINGS Co., Ltd (4671) AI Stock Analysis

1 Followers
JP:4671

FALCO HOLDINGS Co., Ltd

(TSE/TYO:4671)

Select Model
Rating:68Neutral
Price Target:JPY 2,975.00â–²(10.47% Upside)
Action:downgraded
Date:11/18/26

The company's financial health is the primary strength, driven by a robust, debt-free balance sheet and consistent cash flows. Valuation is attractive with a low P/E and high dividend yield. However, technical indicators show mixed momentum with potential near-term overbought conditions, and income statement margins remain under pressure.

Positive Factors
Low LeverageVery low and improving leverage gives FALCO substantial financial flexibility and reduces dependence on borrowing. This strengthens resilience during weaker operating periods while preserving capacity to fund healthcare-service investments, maintain operations, and pursue shareholder returns.
Negative Factors
Margin CompressionLower operating and net margins indicate that recent revenue recovery has not restored the company’s earlier profitability profile. Persistently modest margins leave less room to absorb cost increases or execution setbacks and may constrain the pace at which growth converts into stronger earnings.

FALCO HOLDINGS Co., Ltd (4671) vs. iShares MSCI Japan ETF (EWJ)

-5%0%5%10%15%20%25%30%JP:4671+10.12%EWJ+11.03%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 26.47B
Dividend Yield
4.70%
Average Volume (3M)
18.77K
Price to Earnings (P/E)
12.3
Beta (1Y)
0.52
Revenue Growth
1.19%
EPS Growth
16.02%
Country
Japan
Employees
1,037
Sector
Healthcare
Sector Strength
51
Industry
Medical - Diagnostics & Research

FALCO HOLDINGS Co., Ltd Business Overview & Revenue Model

Company Description

FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various...

FALCO HOLDINGS Co., Ltd Financial Statement Overview

Summary

Strong balance sheet (Score: 85) with minimal debt and growing equity, combined with healthy cash flow generation (Score: 72). Income statement shows moderate profitability with recent revenue growth, though operating margin pressure persists.

Income Statement

58Neutral

Balance Sheet

85Very Positive

Cash Flow

72Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue44.10B43.58B43.31B43.01B46.91B50.01B
Gross Profit14.29B13.81B13.35B12.92B14.64B17.32B
EBITDA4.02B3.56B3.72B3.56B4.75B6.55B
Net Income2.17B2.02B1.92B1.67B2.26B3.53B
Balance Sheet
Total Assets37.04B36.86B36.02B36.42B38.89B40.26B
Cash, Cash Equivalents and Short-Term Investments9.25B9.27B9.42B10.06B12.60B10.64B
Total Debt939.00M1.25B1.44B817.00M2.80B4.07B
Total Liabilities11.25B10.99B10.76B10.40B12.30B16.77B
Stockholders Equity25.79B25.87B25.25B26.03B26.59B23.48B
Cash Flow
Free Cash Flow01.54B1.54B2.19B708.00M1.94B
Operating Cash Flow02.88B2.62B3.43B2.09B4.13B
Investing Cash Flow0-2.03B-1.18B-1.45B322.00M-2.69B
Financing Cash Flow0-2.00B-2.08B-4.53B-448.00M-2.41B

FALCO HOLDINGS Co., Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price2693.00

Price Trends

50DMA2725.78Negative
100DMA2693.18Negative
200DMA2610.13Positive

Market Momentum

MACD1.02Negative
RSI48.75Neutral
STOCH58.84Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4671, the sentiment is Negative. The current price of 2693.00 is above the 20-day moving average (MA) of 2691.25, below the 50-day MA of 2725.78, and above the 200-day MA of 2610.13, indicating a neutral trend. The MACD of 1.02 indicates Negative momentum. The RSI at 48.75 is Neutral, neither overbought nor oversold. The STOCH value of 58.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4671.

FALCO HOLDINGS Co., Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:4671 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4694JP:469476OutperformJPY 148.84B19.815.92%3.20%3.54%10.43%
JP:4671JP:467168NeutralJPY 26.47B12.31―4.70%1.19%16.02%
JP:4538JP:453863NeutralJPY 19.04B8.28―4.15%2.29%―
JP:4579JP:457962NeutralJPY 18.95B42.63――31.84%―
JP:2395JP:239559NeutralJPY 47.79B8.17―4.36%1.89%22.53%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:4563JP:456342NeutralJPY 10.31B-1.77-558.92%―19.67%84.06%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%JP:4671JP:4563JP:4694JP:2395JP:4538JP:4579Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4671 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4671FALCO HOLDINGS Co., Ltd2693.00237.889.69%
JP:4563AnGes 25.00-49.00-66.22%
JP:4694BML 3980.00307.328.37%
JP:2395Shin Nippon Biomedical Laboratories, Ltd.1148.00-491.34-29.97%
JP:4538Fuso Pharmaceutical Industries,Ltd.2170.0060.422.86%
JP:4579RaQualia Pharma Inc.728.0039.005.66%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026